1. Radix Hedysari polysaccharide suppresses lipid metabolism dysfunction in a rat model of non-alcoholic fatty liver disease via adenosine monophosphate-activated protein kinase pathway activation
    WEI-MING SUN et al, 2014 CrossRef
  2. Green Tea in Non-Alcoholic Fatty Liver Disease; A Double Blind Randomized Clinical Trial
    Seyed Mohammad Tabatabaee et al, 2017, Hepat Mon CrossRef
  3. Oily fish, coffee and walnuts: Dietary treatment for nonalcoholic fatty liver disease
    Vikas Gupta, 2015, WJG CrossRef
  4. Isocaloric Dietary Changes and Non-Alcoholic Fatty Liver Disease in High Cardiometabolic Risk Individuals
    Giuseppe Della Pepa et al, 2017, Nutrients CrossRef
  5. Green Tea Extract Protects Against Hepatic NFκB Activation Along The Gut-Liver Axis In Diet-Induced Obese Mice With Nonalcoholic Steatohepatitis By Reducing Endotoxin and TLR4/MyD88 Signaling
    Jinhui Li et al, 2017, The Journal of Nutritional Biochemistry CrossRef
  6. Dietary supplements and pediatric non-alcoholic fatty liver disease: Present and the future
    Mehran Rahimlou, 2015, WJH CrossRef
  7. Medicinal plants and bioactive natural compounds in the treatment of non-alcoholic fatty liver disease: a clinical review
    Mohammad Baghernya et al, 2017, Pharmacological Research CrossRef
  8. Chemopreventive Potential of Green Tea Catechins in Hepatocellular Carcinoma
    Masahito Shimizu et al, 2015, IJMS CrossRef
  9. Comparative studies on the hypolipidemic, antioxidant and hepatoprotective activities of catechin-enriched green and oolong tea in a double-blind clinical trial
    Kamesh Venkatakrishnan et al, 2018, Food Funct. CrossRef
  10. Nrf2 signaling pathway: Pivotal roles in inflammation.
    Syed Minhaj Uddin Ahmed et al, 2017, Biochim Biophys Acta Mol Basis Dis CrossRef
  11. The Potential and Action Mechanism of Polyphenols in the Treatment of Liver Diseases
    Sha Li et al, 2018, Oxidative Medicine and Cellular Longevity CrossRef
  12. Protection by different classes of dietary polyphenols against palmitic acid-induced steatosis, nitro-oxidative stress and endoplasmic reticulum stress in HepG2 hepatocytes
    Hossein Rafiei et al, 2018, Journal of Functional Foods CrossRef
  13. The safety of green tea and green tea extracts consumption in adults – Results of a systematic review
    Jiang Hu et al, 2018, Regulatory Toxicology and Pharmacology CrossRef
  14. An Overview of Novel Dietary Supplements and Food Ingredients in Patients with Metabolic Syndrome and Non-Alcoholic Fatty Liver Disease
    Priscila Silva Figueiredo et al, 2018, Molecules CrossRef
  15. Scientific opinion on the safety of green tea catechins.
    null null et al, 2018, EFSA J CrossRef
  16. Green tea as a safe alternative approach for nonalcoholic fatty liver treatment: A systematic review and meta-analysis of clinical trials
    Fariborz Mansour-Ghanaei et al, 2018, Phytotherapy Research CrossRef
  17. null
    Louis H. S. Lau et al, 2018 CrossRef
  18. Dietary Green Tea Extract Prior to Spinal Cord Injury Prevents Hepatic Iron Overload but does not Improve Chronic Hepatic and Spinal Cord Pathology in Rats
    Matthew Goodus et al, 2018, Journal of Neurotrauma CrossRef
  19. Potential Therapeutic Benefits of Herbs and Supplements in Patients with NAFLD
    Brandon Perumpail et al, 2018, Diseases CrossRef
  20. Ginsenosides, catechins, quercetin and gut microbiota: Current evidence of challenging interactions
    Rosaria Santangelo et al, 2018, Food and Chemical Toxicology CrossRef
  21. Effect of aqueous extract of Allium saralicum R.M. Fritsch on fatty liver induced by high-fat diet in Wistar rats
    Rohallah Moradi et al, 2018, Comp Clin Pathol CrossRef
  22. null
    Cindy X. Cai et al, 2019 CrossRef
  23. Polyphenol intakes and risk of impaired lipid profile, elevated hepatic enzymes and nonalcoholic fatty liver disease
    Mehrnaz Nikkhah-Bodaghi et al, 2019, Nutrition & Food Science CrossRef
  24. Hepatoprotective and cytotoxicity properties of aqueous extract of Glycyrrhiza glabra in Wistar rats fed with high-fat diet
    Samaneh Goorani et al, 2019, Comp Clin Pathol CrossRef
  25. Preventive Efficiency of Green Tea and Its Components on Nonalcoholic Fatty Liver Disease
    Jie Zhou et al, 2019, J. Agric. Food Chem. CrossRef
  26. Non-alcoholic fatty liver disease: need for a balanced nutritional source
    Jayagopalan Veena et al, 2014, Br J Nutr CrossRef
  27. null
    Arpita Basu et al, 2015 CrossRef
  28. Risk Factors Associated With Non-Alcoholic Fatty Liver Disease in Indians: A Case–Control Study
    Shivaram P. Singh et al, 2015, Journal of Clinical and Experimental Hepatology CrossRef
  29. Natural antioxidants for non-alcoholic fatty liver disease: molecular targets and clinical perspectives.
    Federico Salomone et al, 2016, Liver Int CrossRef
  30. Non-alcoholic Fatty Liver Disease: Beneficial Effects of Flavonoids
    Masoumeh Akhlaghi, 2016, Phytother. Res. CrossRef
  31. null
    Arpita Basu et al, 2016 CrossRef
  32. null
    Arpita Basu et al, 2016 CrossRef
  33. Green tea extract treatment reduces NFκB activation in mice with diet-induced nonalcoholic steatohepatitis by lowering TNFR1 and TLR4 expression and ligand availability
    Jinhui Li et al, 2017, The Journal of Nutritional Biochemistry CrossRef
  34. null
    Arpita Basu et al, 2017 CrossRef
  35. Coffee and herbal tea consumption is associated with lower liver stiffness in the general population: The Rotterdam study
    Louise J.M. Alferink et al, 2017, Journal of Hepatology CrossRef
  36. Daily tea drinking is not associated with newly diagnosed non-alcoholic fatty liver disease in Chinese adults: the Tianjin chronic low-grade systemic inflammation and health cohort study
    Yang Xia et al, 2019, Nutr J CrossRef
  37. Mitigation of nonalcoholic fatty liver disease in high-fat-fed mice by the combination of decaffeinated green tea extract and voluntary exercise
    Weslie Y. Khoo et al, 2020, The Journal of Nutritional Biochemistry CrossRef
  38. Hypericin attenuates nonalcoholic fatty liver disease and abnormal lipid metabolism via the PKA-mediated AMPK signaling pathway in vitro and in vivo
    Chen Liang et al, 2020, Pharmacological Research CrossRef
  39. null
    Devaraj Ezhilarasan, 2020 CrossRef
  40. Effects of green tea or green tea catechin on liver enzymes in healthy individuals and people with nonalcoholic fatty liver disease: A systematic review and meta‐analysis of randomized clinical trials
    Marzieh Mahmoodi et al, 2020, Phytotherapy Research CrossRef
  41. Botanical Medicine and Phytochemicals in Healthy Aging and Longevity—Part 2
    Khara Lucius, 2020, Alternative and Complementary Therapies CrossRef
  42. Bioactive compounds and inflammation: an overview
    Giovanna Cavanha Corsi et al, 2020, Nutrire CrossRef
  43. Interaction of Polyphenols as Antioxidant and Anti-Inflammatory Compounds in Brain–Liver–Gut Axis
    Amritpal Singh et al, 2020, Antioxidants CrossRef
  44. Mixtures of Tea and Citrus maxima (pomelo) Alleviate Lipid Deposition in HepG2 Cells Through the AMPK/ACC Signaling Pathway
    Ran An et al, 2020, Journal of Medicinal Food CrossRef
  45. Efficacy of Dietary Supplements to Reduce Liver Fat
    Brittanie Kilchoer et al, 2020, Nutrients CrossRef
  46. Ethyl Acetate Fraction of Amomum xanthioides Ameliorates Nonalcoholic Fatty Liver Disease in a High-Fat Diet Mouse Model
    Hwi-Jin Im et al, 2020, Nutrients CrossRef
  47. Higher flavonoid intake is associated with a lower progression risk of non-alcoholic fatty liver disease in adults: a prospective study
    Qing-wei Zhong et al, 2020, Br J Nutr CrossRef
  48. The effect of adiponectin in the pathogenesis of non-alcoholic fatty liver disease (NAFLD) and the potential role of polyphenols in the modulation of adiponectin signaling
    Samukelisiwe C. Shabalala et al, 2020, Biomedicine & Pharmacotherapy CrossRef
  49. Medicinal plants and bioactive natural compounds as inhibitors of HMG‐CoA reductase: A literature review
    Atena Mahdavi et al, 2020, BioFactors CrossRef
  50. Nutrients, Genetic Factors, and Their Interaction in Non-Alcoholic Fatty Liver Disease and Cardiovascular Disease
    Rosa Lombardi et al, 2020, IJMS CrossRef
  51. (−)-Epigallocatechin-3-O-gallate at a high concentration may induce lipolysis via ATP consumption by activation of stress defense mechanisms
    Satoki Suihara et al, 2021 CrossRef
  52. null
    Venkateish V. Palanisamy et al, 2021 CrossRef
  53. Effects of several tea extracts on nonalcoholic fatty liver disease in mice fed with a high‐fat diet
    Qian‐Qian Mao et al, 2021, Food Sci Nutr CrossRef
  54. null
    Alper Sonmez et al, 2021 CrossRef
  55. null
    Fateme Gharibpour et al, 2021 CrossRef
  56. null
    Atena Mahdavi et al, 2021 CrossRef
  57. Beverages and Non-alcoholic fatty liver disease (NAFLD): Think before you drink
    Jyoti Chhimwal et al, 2021, Clinical Nutrition CrossRef
  58. Effect of Portulaca Oleracea (purslane) extract on liver enzymes, lipid profile, and glycemic status in nonalcoholic fatty liver disease: A randomized, double‐blind clinical trial
    Reyhaneh Darvish Damavandi et al, 2021, Phytotherapy Research CrossRef
  59. Green Tea and Epigallocatechin Gallate (EGCG) for the Management of Nonalcoholic Fatty Liver Diseases (NAFLD): Insights into the Role of Oxidative Stress and Antioxidant Mechanism
    Guoyi Tang et al, 2021, Antioxidants CrossRef
  60. Effects of Nigella sativa, Camellia sinensis, and Allium sativum as Food Additives on Metabolic Disorders, a Literature Review
    Akbar Anaeigoudari et al, 2021, Front. Pharmacol. CrossRef
  61. Understanding the Role of the Gut Microbiome and Microbial Metabolites in Non-Alcoholic Fatty Liver Disease: Current Evidence and Perspectives
    Natalia Vallianou et al, 2021, Biomolecules CrossRef
  62. Regulation of Apolipoprotein B by Natural Products and Nutraceuticals: A Comprehensive Review
    Mohammad Bagherniya et al, 2021, CMC CrossRef
  63. null
    Bhat M. Aalim et al, 2022 CrossRef
  64. Epigallocatechin gallate ameliorates tetrahydrochloride-induced liver toxicity in rats via inhibition of TGFβ / p-ERK/p-Smad1/2 signaling, antioxidant, anti-inflammatory activity
    Gomaa Mostafa-Hedeab et al, 2022, Saudi Pharmaceutical Journal CrossRef
  65. Efficacy and safety of dietary polyphenol supplementation in the treatment of non-alcoholic fatty liver disease: A systematic review and meta-analysis
    Kailin Yang et al, 2022, Front. Immunol. CrossRef
  66. null
    Theano Stoikidou et al, 2023 CrossRef
  67. Effect of portulaca oleracea (purslane) extract on inflammatory factors in nonalcoholic fatty liver disease: A randomized, double-blind clinical trial
    Reyhaneh Darvish Damavandi et al, 2023, Journal of Functional Foods CrossRef
  68. Epigallocatechin gallate alleviates high-fat diet-induced hepatic lipotoxicity by targeting mitochondrial ROS-mediated ferroptosis
    Shi-Bin Ding et al, 2023, Front. Pharmacol. CrossRef
  69. Current innovations in nutraceuticals and functional foods for intervention of non-alcoholic fatty liver disease
    Mengyao Zhao et al, 2021, Pharmacological Research CrossRef
  70. Therapeutic potential of bioactive phytoconstituents found in fruits in the treatment of non-alcoholic fatty liver disease: A comprehensive review
    Manash Pratim Pathak et al, 2023, Heliyon CrossRef
  71. The association of dietary phytochemical index and nonalcoholic fatty liver disease
    Bijan Ahmadi et al, 2023, Food Science & Nutrition CrossRef
  72. Therapeutic Potential of Herbal Medicine against Non-alcoholic Fatty Liver Disease
    Ghazaleh Pourali et al, 2023, CDT CrossRef
  73. Pomegranate (Punica granatum L.) peel extract ameliorates metabolic syndrome risk factors in patients with non-alcoholic fatty liver disease: a randomized double-blind clinical trial
    Hanieh Barghchi et al, 2023, Nutr J CrossRef
  74. Effect of Complementary Therapy with Hydro-Ethanolic Extract of Aerial Parts of Portulaca oleracea on Clinical and Paraclinical Findings in Patients with Non-alcoholic Fatty Liver Disease: A Randomized Clinical Trial Protocol
    Narges Milkarizi et al, 2023, Hepat Mon CrossRef
  75. Ameliorative role of bioactive phytoconstituents targeting obesity associated NAFLD by modulation of inflammation and lipogenesis pathways: a comprehensive review
    Pervej Alom Barbhuiya et al, 2023, Phytochem Rev CrossRef
  76. The Effect of Milk Thistle, Green Tea, and Cinnamon Beverages on Liver Enzymes of Operating Room Anesthesia Personnel
    Vahid Kheirandish et al, 2023, Trends Med Sci CrossRef
  77. Lactobacillus Casei-fermented Amomum Xanthioides Mitigates non-alcoholic fatty liver disease in a high-fat diet mice model
    Seung-Ju Hwang et al, 2024, Biomedicine & Pharmacotherapy CrossRef
  78. Dietary chlorogenic acid alleviates high-fat diet-induced steatotic liver disease by regulating metabolites and gut microbiota
    Yujuan Yu et al, 2024, International Journal of Food Sciences and Nutrition CrossRef
  79. Hepatoprotective effects and mechanisms of l‐theanine and epigallocatechin gallate combined intervention in alcoholic fatty liver rats
    Kai‐Hang Xu et al, 2024, J Sci Food Agric CrossRef
  80. Effects of different natural products in patients with non‐alcoholic fatty liver disease—A network meta‐analysis of randomized controlled trials
    Hongshuai Liu et al, 2024, Phytotherapy Research CrossRef